التفاصيل البيبلوغرافية
العنوان: |
Clot mass loss for the treatment arms tested in this study as a function of the lytic rt-PA concentration. |
المؤلفون: |
Samuel A. Hendley (11902187), Aarushi Bhargava (9735590), Christy K. Holland (4031600), Geoffrey D. Wool (11902190), Osman Ahmed (524943), Jonathan D. Paul (7927310), Kenneth B. Bader (11902193) |
سنة النشر: |
2022 |
المجموعة: |
Smithsonian Institution: Digital Repository |
مصطلحات موضوعية: |
Medicine, Cell Biology, Pharmacology, Immunology, Developmental Biology, Cancer, Hematology, Infectious Diseases, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, red blood cells, directed thrombolysis ), current pharmacomechanical treatments, cover larger areas, focused ultrasound therapy, div >< p, deep vein thrombosis, common clinical dose, still promote fibrinolysis, directed thrombolytic therapy, directed thrombolysis combined, highest lytic dose, histotripsy p, thrombolytic therapy, p >(, vitro <, venous thrombosis, lytic dose, thrombolytic agent, pa dose |
الوصف: |
The legend indicates the insonation scheme (histotripsy was not applied for the ‘Lytic Alone’ arm). Stars indicate statistically significant increases in mass loss for a given rt-PA dose (p < 0.05). The blue triangle indicates an increased mass loss compared to the standard of care arm (4.54 μg/mL rt-PA only). |
نوع الوثيقة: |
still image |
اللغة: |
unknown |
Relation: |
https://figshare.com/articles/figure/Clot_mass_loss_for_the_treatment_arms_tested_in_this_study_as_a_function_of_the_lytic_rt-PA_concentration_/17858225 |
DOI: |
10.1371/journal.pone.0261567.g003 |
الاتاحة: |
https://doi.org/10.1371/journal.pone.0261567.g003 |
Rights: |
CC BY 4.0 |
رقم الانضمام: |
edsbas.C968DB59 |
قاعدة البيانات: |
BASE |